Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 1 of about 1   

Articles published

NVS 76.81 +0.84 (1.11%)
price chart
New pharmacovigilance system debuts in EU
New rules governing the monitoring, identification and assessment of adverse events caused by pharmaceuticals are introduced, with the aim of making the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.